Owning the megacap-growth trade in one ticker used to mean paying up for a marquee name like Invesco QQQ Trust (NASDAQ:QQQ) or leaning on Vanguard’s growth index. The iShares Russell Top 200 Growth ETF (NYSEARCA:IWY) has quietly delivered a solid ten-year math.
IWY packages the largest-cap growth names in the US market, and over the trailing decade it has returned 451% versus the S&P 500’s 306%. If you already lean growth, IWY is the fund you probably underweighted because you had never heard of it.
What IWY Actually Owns And How It Makes Money
IWY tracks the Russell Top 200 Growth Index, the growth half of the 200 largest US stocks, sliced by book-to-price, sales growth, and earnings momentum. The return engine is capital appreciation from megacap compounders. Cash is essentially fully deployed, with less than 1% in equivalents.
The concentration is the whole story. NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) sits at 15%, Apple (NASDAQ:AAPL) at 13%, and Microsoft (NASDAQ:MSFT) at 10%. Add Amazon (NASDAQ:AMZN), Broadcom (NASDAQ:AVGO), both share classes of Alphabet, Meta, Eli Lilly, and Visa, and you reach 62% of the fund in ten names. On a $16.9 billion asset base, IWY is effectively a leveraged bet that those ten franchises will continue to defend margins and grow the top line at premium multiples.
Does The Record Justify The Bet
Over ten years, the answer is yes, and by a wide margin. IWY’s annualized ten-year return is 18%, turning $1,000 into $5,163. That is roughly double what a plain S&P 500 index has done over the same period, and it happened while charging a 0.20% fee, which is expensive relative to Vanguard’s growth index but cheap enough to compound without noticeable drag.
Five-year numbers still favor IWY at 87% against SPY’s 85%. The trailing twelve months are where the story bends. IWY is up 12%, but the S&P returned 20%, and year-to-date IWY has gained only 1.4% against 10% for the broad index.
The Real Tradeoffs
- Top-heavy by design. The top ten US stocks now account for roughly 35% of the overall market, up from just 18% a decade ago. IWY sits at the extreme end of that concentration curve. When a single earnings miss can move the fund a full percent, the diversification claim is mostly marketing.
- Growth factor cyclicality. The valuation math only works as long as these names keep growing into premium multiples. Apple trades near 44x earnings and NVIDIA near 42x. In a rotation to value or small caps, IWY becomes the wrong end of the trade.
- Near-identical to its cheaper cousins. Vanguard Growth ETF (NYSEARCA:VUG) returned 406% over ten years, and Schwab U.S. Large-Cap Growth ETF (NYSEARCA:SCHG) returned 445%. IWY edged both, but both charge less. QQQ delivered 527% over the same window, with a greater tech tilt.
Who Should Own It And Who Should Not
IWY earns a spot as a 10% to 20% growth sleeve for long-term investors who understand they are buying concentrated exposure to a handful of American compounders and can stomach a year like the current one, when megacaps trail the broad tape. The ten-year record is real, the fee is defensible, and the methodology is transparent.
If your S&P 500 fund already holds NVIDIA, Apple, and Microsoft near the top, adding IWY just doubles down on the same names. And if fee obsession is the deciding factor, SCHG delivers 97% of the same portfolio for less. IWY is the quiet overachiever of the megacap-growth aisle. Just know what quiet is doing in your portfolio before you buy more of it.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks